Vaccines E-Book : Vaccines E-Book（7）

著者名：Orenstein MD, DSc (HON), Walter A./Offit MD, Paul A./Edwards MD, Kathryn M./Plotkin MD, Stanley A.

Elsevier（2017/04/07発売）

• 言語：ENG
• ISBN：9780323357616
• eISBN：9780323393010

Description

From the development of each vaccine to its use in reducing disease, Plotkin's Vaccines, 7th Edition, provides the expert information you need to provide optimal care to your patients. This award-winning text offers a complete understanding of each disease, as well as the latest knowledge of both existing vaccines and those currently in research and development. Described by Bill Gates as "an indispensable guide to the enhancement of the well-being of our world," Plotkin's Vaccines is a must-have reference for current, authoritative information in this fast-moving field.- Includes complete information for each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, epidemiology, and public health and regulatory issues – plus complete information for each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.- Analyzes the cost-benefit and cost-effectiveness of different vaccine options.- Helps you clearly visualize concepts and objective data through an abundance of tables and figures.- Covers the new oral cholera and zoster vaccines, as well as newly licensed meningococcal group B vaccines and a newly licensed dengue vaccine.- Brings you up to date on successful human trials of Ebola vaccines, an enterovirus 71 vaccine licensed in China, and new recommendations and changes to polio vaccines.- Features a new chapter on maternal immunization.- Expert Consult™ eBook version included with purchase. This enhanced eBook experience allows you to search all of the text, figures, and references from the book on a variety of devices.

Table of Contents

Section 1: General Aspects of Vaccination1. A Short History of Vaccination2. Vaccine Immunology3. Correlates of Protection4. The Vaccine Industry5. Vaccine Manufacturing6. Evolution of Adjuvants Across the Centuries7. Vaccine Additives and Manufacturing Residuals in Vaccines Licensed in the United States8. Passive Immunization9. General Immunization PracticesSection 2: Licensed Vaccines and Vaccines in Development10. Adenovirus Vaccines11. Anthrax Vaccines12. Biodefense and Special Pathogen Vaccines13. Cancer Vaccines14. Cholera Vaccines15. Combination Vaccines16. Cytomegalovirus Vaccines17. Dengue Vaccines18. Diarrhea Caused by Bacteria19. Diphtheria Toxoid20. Ebola Vaccines21. Enterovirus 7122. Epstein-Barr Virus Vaccines23. Haemophilus influenzae Type b Vaccines24. Hepatitis A Vaccines25. Hepatitis B Vaccines26. Hepatitis C Vaccines27. Hepatitis E Vaccines28. Herpes Simplex Virus Vaccines29. Human Immunodeficiency Virus Vaccines30. Human Papillomavirus Vaccines31. Inactivated Influenza Vaccines32. Influenza Vaccine—Live33. Japanese Encephalitis Vaccines34. Lyme Disease Vaccines35. Malaria Vaccines36. Maternal Immunization37. Measles Vaccines38. Meningococcal Capsular Group A, C, W, and Y Conjugate Vaccines39. Meningococcal Capsular Group B Vaccines40. Mumps Vaccines41. Noninfectious Disease Vaccines42. Norovirus Vaccines43. Parasitic Disease Vaccines44. Pertussis Vaccines45. Plague Vaccines46. Pneumococcal Conjugate Vaccine and Pneumococcal Common Protein Vaccines47. Pneumococcal Polysaccharide Vaccines48. Poliovirus Vaccine–Inactivated49. Poliovirus Vaccine–Live50. Rabies Vaccines51. Respiratory Syncytial Virus Vaccines52. Rotavirus Vaccines53. Rubella Vaccines54. Smallpox and Vaccinia55. Staphylococcus aureus Vaccines56. Streptococcus Group A Vaccines57. Streptococcus Group B Vaccines58. Tetanus Toxoid59. Tickborne Encephalitis Vaccines60. Tuberculosis Vaccines61. Typhoid Fever Vaccines62. Varicella Vaccines63. Yellow Fever Vaccines64. Zika Virus65. Zoster VaccinesSection 3: New Technologies66. Technologies for Making New Vaccines67. Development of Gene-Based Vectors for Immunization68. Technologies to Improve ImmunizationSection 4: Vaccination of Special Groups69. Vaccination of Immunocompromised Hosts70. Vaccination of Human Immunodeficiency Virus–Infected Persons71. Vaccines for International Travel72. Vaccines for Healthcare PersonnelSection 5: Public Health and Regulatory Issues73. Immunization in the United States74. Immunization in Europe75. Immunization in the Asia-Pacific Region76. Immunization in Developing Countries77. Community Protection78. Economic Analyses of Vaccine Policies79. Regulation and Testing of Vaccines80. Regulation of Vaccines in Europe81. Regulation of Vaccines in Low- and Middle-Income Countries82. Vaccine Safety83. Legal Issues84. EthicsAppendix: Websites and Applications for Mobile Devices with Information about Immunization